Robert Kralovics

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 14

Top Venues

American journal of hematology

Blood

Leukemia

The Journal of experimental medicine

Medizinische Universität Wien

Academy of Sciences of the Czech Republic (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medizinische Universität Wien Jun 01 2018

Austria

Principal Investigator :: Laboratory Medicine

Research Center for Molecular Medicine of the Austrian Academy of Sciences Jun 01 2006 - May 31 2018

Austria

Principal Investigator

Education History

Academy of Sciences of the Czech Republic Sep 01 1993 - Jan 07 1997

Czechia

PHD :: Institute of Biophysics

Publications

Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Carl Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian, null null
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment. Leukemia (2023)
Daniel Ivanov, Jelena D M Feenstra, Irina Sadovnik, Harald Herrmann, Barbara Peter, Michael Willmann, Georg Greiner, Katharina Slavnitsch, Emir Hadzijusufovic, Thomas Rülicke, Maik Dahlhoff, Gregor Hoermann, Sigrid Machherndl-Spandl, Gregor Eisenwort, Michael Fillitz, Thamer Sliwa, Maria-Theresa Krauth, Peter Bettelheim, Wolfgang R Sperr, Elisabeth Koller, Michael Pfeilstöcker, Heinz Gisslinger, Felix Keil, Robert Kralovics, Peter Valent
Phenotypic Characterization of Disease-Initiating Stem Cells in JAK2- or CALR-mutated Myeloproliferative Neoplasms. American journal of hematology (2023)
Daniel Ivanov, Jelena D M Feenstra, Irina Sadovnik, Harald Herrmann, Barbara Peter, Michael Willman, Georg Greiner, Katharina Slavnitsch, Emir Hadzijusufovic, Thomas Rülicke, Maik Dahlhoff, Gregor Hoermann, Sigrid Machherndl-Spandl, Gregor Eisenwort, Michael Fillitz, Thamer Sliwa, Maria-Theresa Krauth, Peter Bettelheim, Wolfgang R Sperr, Elisabeth Koller, Michael Pfeilstöcker, Heinz Gisslinger, Felix Keil, Robert Kralovics, Peter Valent
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms. American journal of hematology (2023)
Jelena D M Feenstra, Roland Jäger, Fiorella Schischlik, Daniel Ivanov, Gregor Eisenwort, Elisa Rumi, Michael Schuster, Bettina Gisslinger, Sigrid Machherndl-Spandl, Peter Bettelheim, Maria-Theresa Krauth, Felix Keil, Christoph Bock, Mario Cazzola, Heinz Gisslinger, Robert Kralovics, Peter Valent
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms. American journal of hematology 97 (4) (2022)
Christina M Schueller, Andrea Majoros, Harini Nivarthi, Robert Kralovics
Co-expression of mutated Jak2 and Calr enhances myeloproliferative phenotype in mice without loss of stem cell fitness. American journal of hematology 97 (11) (2022)
Jean-Jacques Kiladjian, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Carl Hasselbalch, Robert Kralovics, Heinz Gisslinger, null null
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b. Leukemia 36 (5) (2022)
Sarada Achyutuni, Harini Nivarthi, Andrea Majoros, Eva Hug, Christina M Schueller, Ruochen Jia, Cecilia Varga, Michael Schuster, Martin Senekowitsch, Dimitris Tsiantoulas, Anoop Kavirayani, Christoph J Binder, Christoph Bock, Oleh Zagrijtschuk, Robert Kralovics
Hematopoietic expression of a chimeric murine-human CALR oncoprotein allows the assessment of anti-CALR antibody immunotherapies in vivo. American journal of hematology 96 (6) (2021)
Ruochen Jia, Leon Kutzner, Anna Koren, Kathrin Runggatscher, Peter Májek, André C Müller, Michael K Schuster, Christoph Bock, Joanna I Loizou, Stefan Kubicek, Robert Kralovics
High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells. Blood cancer journal 11 (7) (2021)
Ivanna Subtelna, Anna Kryshchyshyn, Ruochen Jia, Maryan Lelyukh, Anna Ringler, Stefan Kubicek, Oleh Zagrijtschuk, Robert Kralovics, Roman Lesyk
5-Arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones with selective inhibitory activity against some leukemia cell lines. Archiv der Pharmazie 354 (4) (2020)
Iris Z Uras, Barbara Maurer, Harini Nivarthi, Philipp Jodl, Karoline Kollmann, Michaela Prchal-Murphy, Jelena D M Feenstra, Markus Zojer, Sabine Lagger, Reinhard Grausenburger, Beatrice Grabner, Raimund Holly, Anoop Kavirayani, Christoph Bock, Heinz Gisslinger, Peter Valent, Robert Kralovics, Veronika Sexl
CDK6 coordinates JAK2 V617F mutant MPN via NF-κB and apoptotic networks. Blood 133 (15) (2019)
Ruochen Jia, Robert Kralovics
Progress in elucidation of molecular pathophysiology of myeloproliferative neoplasms and its application to therapeutic decisions. International journal of hematology 111 (2) (2019)
Katarina Kapralova, Monika Horvathova, Christian Pecquet, Jana Fialova Kucerova, Dagmar Pospisilova, Emilie Leroy, Barbora Kralova, Jelena D M Feenstra, Fiorella Schischlik, Robert Kralovics, Stefan N Constantinescu, Vladimir Divoky
Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia. Blood 128 (10) (2016)
Takafumi Shimizu, Lucia Kubovcakova, Ronny Nienhold, Jakub Zmajkovic, Sara C Meyer, Hui Hao-Shen, Florian Geier, Stephan Dirnhofer, Paola Guglielmelli, Alessandro Maria Maria Vannucchi, Jelena D Milosevic Feenstra, Robert Kralovics, Stuart H Orkin, Radek C Skoda
Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis. The Journal of experimental medicine 213 (8) (2016)
William Vainchenker, Robert Kralovics
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood 129 (6) (2016)

Robert Kralovics.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Robert Kralovics